Limits...
Trends in malignant intraductal papillary mucinous neoplasm in US adults from 1990 to 2010: a SEER database analysis.

McCarty TR, Njei B - Gastroenterol Rep (Oxf) (2016)

Bottom Line: Performance of surgery (HR: 0.45, 95% CI: 0.40-0.53, P < 0.001) was associated with a decreased risk of death.There was also no improvement observed in long-term survival.The small percentage of eligible cases receiving surgical treatment suggests that there is room for further improvement in survival, with increased utilization of surgery.

View Article: PubMed Central - PubMed

Affiliation: Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

No MeSH data available.


Related in: MedlinePlus

Rates of IPMN diagnosis and surgery from 1990 to 2010.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4863191&req=5

gov066-F1: Rates of IPMN diagnosis and surgery from 1990 to 2010.

Mentions: Of the 2651 patients included, 564 (21.3%) underwent a surgical procedure (Table 3). The mean age of patients undergoing surgery was 66.8 years with a slight female predominance (n = 292, 51.8%). The majority of surgical candidates were white as well (n = 453, 80.3%). SEER historic stage in this subset of surgical patients revealed regional staging in 50.5% with spread to regional lymph nodes. Head of the pancreas was the most common location of tumor in patients who underwent surgery (n = 202, 35.8%). The most common procedure type amongst this cohort included pancreatoduodenectomy or Whipple (n = 402, 71.3%). The number of patients who underwent surgery from 1990 to 2010 also decreased slightly when comparing an initial 6-year period to the final 5-year period of this study (n = 132 during 1990–1995 to n = 96 during 2006–2010). Rates of diagnosis and surgery are shown in Figure 1. A linear data analysis regarding surgical percentage of IPMN annually (not by quartiles) demonstrated that the highest percentages of surgery-related cases occurred in 1999 (30.12%) as shown in Supplemental Table 6.Figure 1


Trends in malignant intraductal papillary mucinous neoplasm in US adults from 1990 to 2010: a SEER database analysis.

McCarty TR, Njei B - Gastroenterol Rep (Oxf) (2016)

Rates of IPMN diagnosis and surgery from 1990 to 2010.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4863191&req=5

gov066-F1: Rates of IPMN diagnosis and surgery from 1990 to 2010.
Mentions: Of the 2651 patients included, 564 (21.3%) underwent a surgical procedure (Table 3). The mean age of patients undergoing surgery was 66.8 years with a slight female predominance (n = 292, 51.8%). The majority of surgical candidates were white as well (n = 453, 80.3%). SEER historic stage in this subset of surgical patients revealed regional staging in 50.5% with spread to regional lymph nodes. Head of the pancreas was the most common location of tumor in patients who underwent surgery (n = 202, 35.8%). The most common procedure type amongst this cohort included pancreatoduodenectomy or Whipple (n = 402, 71.3%). The number of patients who underwent surgery from 1990 to 2010 also decreased slightly when comparing an initial 6-year period to the final 5-year period of this study (n = 132 during 1990–1995 to n = 96 during 2006–2010). Rates of diagnosis and surgery are shown in Figure 1. A linear data analysis regarding surgical percentage of IPMN annually (not by quartiles) demonstrated that the highest percentages of surgery-related cases occurred in 1999 (30.12%) as shown in Supplemental Table 6.Figure 1

Bottom Line: Performance of surgery (HR: 0.45, 95% CI: 0.40-0.53, P < 0.001) was associated with a decreased risk of death.There was also no improvement observed in long-term survival.The small percentage of eligible cases receiving surgical treatment suggests that there is room for further improvement in survival, with increased utilization of surgery.

View Article: PubMed Central - PubMed

Affiliation: Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA.

No MeSH data available.


Related in: MedlinePlus